CSIG-21. THE ROLE OF miR-219a-2-3p AS A TUMOR SUPPRESSOR IN IDH1/2-WILD-TYPE GRADE II/III GLIOMAS

IDH1/2 mutation status can accurately stratify distinct groups of lower-grade glioma (LGG) patients with IDH1/2 non-mutant patients having significantly worse survival rates. A better understanding of the molecular alterations in IDH1/2 mutant versus non-mutant patients may lead to new therapeutic o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Fleming, Jessica, Hlavin Bell, Erica, Tong, Zhen-yue, Grozdic, Ivana, McElroy, Joseph, Beyer, Sasha, Fabian, Denise, Cui, Tiantian, Popp, Ilinca, Staszewski, Ori, Prinz, Marco, Jaharul Haque, Saikh, Grosu, Anca-Ligia, Chakravarti, Arnab
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216663/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars